All Stories

  1. Patients’ UX Impact on Medication Adherence in Czech Pilot Study for Chronically Ill

    Article • Behavioral Sciences, June 2024, MDPI AG

    Professor MICHAEL GORDON SCOTT

  2. Antimicrobial prescribing in a secondary care setting during the COVID-19 pandemic

    Article • JAC-Antimicrobial Resistance, November 2023, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  3. Oral nutritional supplements in care homes

    Article • Journal of Prescribing Practice, October 2023, Mark Allen Group

    Professor MICHAEL GORDON SCOTT

  4. Clinical pharmacy interventions in an Austrian hospital: a report highlights the need for the implementation of clinical pharmacy services

    Article • European Journal of Hospital Pharmacy, September 2023, BMJ

    Professor MICHAEL GORDON SCOTT

  5. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

    Article • Frontiers in Pharmacology, August 2023, Frontiers

    Professor MICHAEL GORDON SCOTT

  6. The impact of the COVID‐19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland

    Article • British Journal of Clinical Pharmacology, May 2023, Wiley

    Professor MICHAEL GORDON SCOTT

  7. C-reactive protein point of care testing in community pharmacy: Observational study of a Northern Ireland pilot

    Article • Pharmacy Practice, December 2022, JCFCorp SG PTE LTD

    Professor MICHAEL GORDON SCOTT

  8. Adherence to metformin in adults with type 2 diabetes: a combined method approach

    Article • Journal of Pharmaceutical Policy and Practice, October 2022, Taylor & Francis

    Professor MICHAEL GORDON SCOTT

  9. Minding the gap-an examination of a pharmacist case management medicines optimisation intervention for older people in intermediate care settings

    Article • Research in Social and Administrative Pharmacy, September 2022, Elsevier

    Professor MICHAEL GORDON SCOTT

  10. Ensuring the quality and quantity of personal protective equipment (PPE) by enhancing the procurement process in Northern Ireland during the coronavirus disease 2019 pandemic: Challenges in the procurement process for PPE in NI

    Article • Journal of Patient Safety and Risk Management, November 2021, SAGE Publications

    Professor MICHAEL GORDON SCOTT

  11. Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland

    Article • Pharmacy, October 2021, MDPI AG

    Professor MICHAEL GORDON SCOTT

  12. Factors Facilitating and Hindering Development of a Medication Use Review Service in Eastern Europe and Iran-Cross-Sectional Exploratory Study

    Article • Healthcare, September 2021, MDPI AG

    Professor MICHAEL GORDON SCOTT, Piotr Merks

  13. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

    Article • The Lancet Healthy Longevity, March 2021, Elsevier

    Professor MICHAEL GORDON SCOTT

  14. Shaping the Future of Digitally Enabled Health and Care

    Article • Pharmacy, January 2021, MDPI AG

    Professor MICHAEL GORDON SCOTT

  15. General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

    Article • Journal of Pharmaceutical Policy and Practice, January 2021, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  16. Author Correction: A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance

    Article • Nature Microbiology, September 2020, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  17. Informing critical care drug requirements in response to the COVID-19 pandemic

    Article • European Journal of Hospital Pharmacy, July 2020, BMJ

    Professor MICHAEL GORDON SCOTT

  18. COvid MEdicaTion (COMET) study: protocol for a cohort study

    Article • European Journal of Hospital Pharmacy, June 2020, BMJ

    Professor MICHAEL GORDON SCOTT

  19. A novel approach to medicines optimisation post-discharge from hospital: pharmacist-led medicines optimisation clinic

    Article • International Journal of Clinical Pharmacy, June 2020, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  20. Analysis of activities undertaken by ward-based clinical pharmacy technicians during patient hospital journey

    Article • European Journal of Hospital Pharmacy, October 2019, BMJ

    Professor Kathryn Burnett, Professor MICHAEL GORDON SCOTT

  21. Influence of primary care antibiotic prescribing on incidence rates of multidrug-resistant Gram-negative bacteria in hospitalised patients

    Article • Infection, May 2019, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  22. A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance

    Article • Nature Microbiology, April 2019, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  23. Ensuring continuity of patient care across the healthcare interface: Telephone follow‐up post‐hospitalization

    Article • British Journal of Clinical Pharmacology, January 2019, Wiley

    Professor MICHAEL GORDON SCOTT

  24. Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings

    Article • Emerging Infectious Diseases, January 2019, Centers for Disease Control and Prevention (CDC)

    Professor MICHAEL GORDON SCOTT

  25. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan

    Article • BMC Health Services Research, November 2018, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  26. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

    Article • The Lancet Global Health, June 2018, Elsevier

    Professor MICHAEL GORDON SCOTT

  27. Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study

    Article • British Journal of Clinical Pharmacology, January 2018, Wiley

    Professor MICHAEL GORDON SCOTT

  28. Evaluation of bactericidal and anti-biofilm properties of a novel surface-active organosilane biocide against healthcare associated pathogens and Pseudomonas aeruginosa biolfilm

    Article • PLOS One, August 2017, PLOS

    Professor MICHAEL GORDON SCOTT

  29. Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach

    Article • Drug Healthcare and Patient Safety, July 2017, Dove Medical Press

    Professor MICHAEL GORDON SCOTT, Mamoon Aldeyab

  30. Reduction in the incidence of hospital-acquired MRSA following the introduction of a chlorine dioxide 275 ppm based disinfecting agent in a district general hospital

    Article • European Journal of Hospital Pharmacy, August 2015, BMJ

    Professor MICHAEL GORDON SCOTT

  31. Enhanced clinical pharmacy service targeting tools: risk-predictive algorithms

    Article • Journal of Evaluation in Clinical Practice, December 2014, Wiley

    Professor MICHAEL GORDON SCOTT

  32. Tackling the problem of blood culture contamination in the intensive care unit using an educational intervention

    Article • Epidemiology and Infection, November 2014, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  33. Risk factors associated with Clostridium difficile infection severity in hospitalized patients

    Article • American Journal of Infection Control, June 2014, Elsevier

    Professor MICHAEL GORDON SCOTT

  34. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking

    Article • Journal of Antimicrobial Chemotherapy, November 2013, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  35. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings

    Article • Epidemiology and Infection, June 2013, Cambridge University Press

    Mamoon Aldeyab, Professor MICHAEL GORDON SCOTT

  36. The Antibiotic Resistance and Prescribing in European Children Project

    Article • The Pediatric Infectious Disease Journal, June 2013, Wolters Kluwer Health

    Professor MICHAEL GORDON SCOTT

  37. Hospital antibiotic use and its relationship to age-adjusted comorbidity and alcohol-based hand rub consumption

    Article • Epidemiology and Infection, May 2013, Cambridge University Press

    Mamoon Aldeyab, Professor MICHAEL GORDON SCOTT

  38. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings

    Article • Journal of Antimicrobial Chemotherapy, August 2012, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  39. Product standardisation as a tool to control prescribing costs – a case study of alginate liquid preparations

    Article • International Journal of Pharmacy Practice, July 2012, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  40. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings

    Article • British Journal of Clinical Pharmacology, June 2012, Wiley

    Professor MICHAEL GORDON SCOTT

  41. A point prevalence survey of antibiotic use in four acute-care teaching hospitals utilizing the European Surveillance of Antimicrobial Consumption (ESAC) audit tool

    Article • Epidemiology and Infection, November 2011, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  42. Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people

    Article • Journal of Evaluation in Clinical Practice, August 2011, Wiley

    Professor MICHAEL GORDON SCOTT

  43. An Evaluation of the Impact of a Single-Dose Intravenous Immunoglobulin Regimen in the Treatment of Clostridium difficile Infections

    Article • Infection Control, June 2011, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  44. Integrated medicines management - can routine implementation improve quality?

    Article • Journal of Evaluation in Clinical Practice, April 2011, Wiley

    Professor MICHAEL GORDON SCOTT

  45. Multihospital Outbreak ofClostridium difficileRibotype 027 Infection: Epidemiology and Analysis of Control Measures

    Article • Infection Control, March 2011, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  46. Clinical and economic impact of contaminated blood cultures within the hospital setting

    Article • Journal of Hospital Infection, March 2011, Elsevier

    Professor MICHAEL GORDON SCOTT

  47. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use

    Article • British Journal of Clinical Pharmacology, January 2011, Wiley

    Professor MICHAEL GORDON SCOTT

  48. Strategy for improving and maintaining compliance with adequate hospital hand hygiene practices

    Article • Journal of Hospital Infection, January 2011, Elsevier

    Professor MICHAEL GORDON SCOTT

  49. Improving and maintaining adherence with hospital antibiotic policies: a strategy for success

    Article • Journal of Hospital Infection, January 2011, Elsevier

    Professor MICHAEL GORDON SCOTT

  50. Practical steps to deal with meticillin-resistant Staphylococcus aureus in hospitals

    Article • Journal of Hospital Infection, June 2010, Elsevier

    Professor MICHAEL GORDON SCOTT

  51. An Evaluation of Compliance with an Antibiotic Policy in Surgical Wards at a General Teaching Hospital in Northern Ireland

    Article • Infection Control, September 2009, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  52. Health-Related Quality of Life after Intensive Care Unit Discharge: A Comparison between 2 Standard Antibiotic Regimens

    Article • Infection Control, August 2009, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  53. Effects of an integrated medicines management program on medication appropriateness in hospitalized patients

    Article • American Journal of Health-System Pharmacy, May 2009, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  54. Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile-Associated Diarrhea in Hospitalized Patients

    Article • Antimicrobial Agents and Chemotherapy, March 2009, ASM Journals

    Professor MICHAEL GORDON SCOTT

  55. Evaluation of the Efficacy of a Conventional Cleaning Regimen in Removing Methicillin-ResistantStaphylococcus aureusFrom Contaminated Surfaces in an Intensive Care Unit

    Article • Infection Control, March 2009, Cambridge University Press

    Professor MICHAEL GORDON SCOTT

  56. Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus?

    Article • Journal of Hospital Infection, January 2009, Elsevier

    Professor MICHAEL GORDON SCOTT

  57. Comparison of the effect of ciprofloxacin and Tazocin® on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit

    Article • International Journal of Antimicrobial Agents, December 2008, Elsevier

    Professor MICHAEL GORDON SCOTT

  58. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis

    Article • Journal of Antimicrobial Chemotherapy, June 2008, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  59. An innovative approach to integrated medicines management

    Article • Journal of Evaluation in Clinical Practice, October 2007, Wiley

    Professor MICHAEL GORDON SCOTT

  60. Impact of Modified System of Objectified Judgement Analysis (SOJA) Methodology on Prescribing Costs of ACE Inhibitors

    Article • Clinical Drug Investigation, January 2006, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  61. A HRG-based costing model for estimating pharmacy costs associated with surgical procedures

    Article • Journal of Clinical Pharmacy and Therapeutics, June 2004, Hindawi Publishing Corporation

    Professor MICHAEL GORDON SCOTT

  62. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland

    Article • Pharmacy World & Science, April 2004, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  63. Management of Helicobacter pylori eradication - the influence of structured counselling and follow-up

    Article • British Journal of Clinical Pharmacology, January 2002, Wiley

    Professor MICHAEL GORDON SCOTT

  64. Article • Pharmacy World & Science, January 2002, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  65. Clostridium difficile-associated diarrhoea in hospitalised patients

    Article • Journal of Clinical Pharmacy and Therapeutics, April 2000, Hindawi Publishing Corporation

    Professor MICHAEL GORDON SCOTT

  66. Use of a treatment protocol in the management of community-acquired lower respiratory tract infection

    Article • Journal of Antimicrobial Chemotherapy, March 2000, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  67. Article • Pharmacy World & Science, January 2000, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  68. Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children

    Article • Journal of Antimicrobial Chemotherapy, November 1999, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  69. Buccal absorption of enalapril and lisinopril

    Article • European Journal of Clinical Pharmacology, November 1998, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  70. Using bar-code technology to capture clinical intervention data in a hospital with a stand-alone pharmacy computer system

    Article • American Journal of Health-System Pharmacy, March 1996, Oxford University Press (OUP)

    Professor MICHAEL GORDON SCOTT

  71. A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure

    Article • European Journal of Clinical Pharmacology, March 1996, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  72. Audit of antibiotic usage in a medium-sized general hospital over an 11-year period

    Article • Pharmacy World & Science, November 1995, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  73. The effect of pH on the buccal and sublingual absorption of captopril

    Article • European Journal of Clinical Pharmacology, September 1995, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  74. Short Comunication: A Comparison of Agiolax and Lactulose in Elderly Patients with Chronic Constipation

    Article • Pharmacology, January 1993, Karger Publishers

    Professor MICHAEL GORDON SCOTT

  75. A pharmacokinetic and pharmacodynamic comparison of plain and enteric- coated prednisolone tablets.

    Article • British Journal of Clinical Pharmacology, May 1992, Wiley

    Professor MICHAEL GORDON SCOTT

  76. Sublingual captopril ? a pharmacokinetic and pharmacodynamic evaluation

    Article • European Journal of Clinical Pharmacology, April 1991, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  77. AUDIOVISUAL DEMONSTRATION FOR PATIENT COUNSELLING IN THE USE OF PRESSURISED AEROSOL BRONCHODILATOR INHALERS

    Article • Journal of Clinical Pharmacy and Therapeutics, April 1989, Hindawi Publishing Corporation

    Professor MICHAEL GORDON SCOTT

  78. Chlordiazepoxide Metabolite Accumulation in Liver Disease

    Article • Medical Toxicology, February 1989, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  79. Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin

    Article • European Journal of Clinical Pharmacology, January 1989, Springer Science + Business Media

    Professor MICHAEL GORDON SCOTT

  80. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.

    Article • British Journal of Clinical Pharmacology, April 1987, Wiley

    Professor MICHAEL GORDON SCOTT